Latest Annual Reports
by Mike Gee
24 May 2026









































Ally Financial Inc.
REVENUE
$7,914,000,000
-3.26%
INCOME
$852,000,000
27.54%
EMPLOYEES
N/A
CUSTOMERS
N/A
Ally Financial Inc. is a bank holding company that operates the nation’s largest all-digital bank and a leading automotive financing and insurance business, with $196.0 billion in assets as of December 31, 2025.
View Company PageFiled: 2026-02-25
Apollo Global Management, Inc.
REVENUE
$32,049,000,000
22.73%
INCOME
$5,401,000,000
-15.25%
EMPLOYEES
4,130
CUSTOMERS
152,000
Apollo Global Management is a global alternative asset manager and retirement services provider (through Athene) with significant principal investing activities, managing $938.4 billion of AUM as of December 31, 2025.
View Company PageFiled: 2026-02-25
ARKO Corp.
REVENUE
$7,643,471,000
-12.47%
INCOME
$22,744,000
9.11%
EMPLOYEES
9,748
CUSTOMERS
2,400,000
ARKO Corp. is a Richmond, Virginia–based operator of convenience stores and a wholesale motor fuel distributor across the United States, operating a Family of Community Brands of retail sites and supplying fuel through dealer, fleet card and cardlock networks.
View Company PageFiled: 2026-02-25
APi Group Corp
REVENUE
$7,911,000,000
12.72%
INCOME
$302,000,000
20.80%
EMPLOYEES
29,000
CUSTOMERS
N/A
APi Group Corporation is a global provider of fire and life safety, electronic security, elevators and escalators, and related specialty services, operating a decentralized model focused on recurring inspection, service, and monitoring revenue.
View Company PageFiled: 2026-02-25
Arcutis Biotherapeutics, Inc.
REVENUE
N/A
INCOME
-$16,141,000
88.47%
EMPLOYEES
354
CUSTOMERS
N/A
Arcutis Biotherapeutics is a commercial-stage biopharmaceutical company focused on developing and commercializing dermatology therapies—primarily topical roflumilast (ZORYVE) products—for inflammatory skin conditions and expanding its pipeline through in‑licensing and partnerships.
View Company PageFiled: 2026-02-25
Arcus Biosciences, Inc.
REVENUE
$247,000,000
-4.26%
INCOME
-$353,000,000
-24.73%
EMPLOYEES
601
CUSTOMERS
N/A
Arcus Biosciences is a late clinical-stage biopharmaceutical company developing differentiated oral small-molecule therapies for oncology and inflammatory/autoimmune diseases, with multiple Phase 3 oncology programs and a preclinical inflammation portfolio.
View Company PageFiled: 2026-02-25
Alector, Inc.
REVENUE
N/A
INCOME
-$142,929,000
-20.06%
EMPLOYEES
103
CUSTOMERS
N/A
Alector is a clinical-stage biotechnology company developing blood–brain barrier‑penetrant therapies (antibodies, enzymes, siRNA) for neurodegenerative diseases using its proprietary Alector Brain Carrier (ABC) platform.
View Company PageFiled: 2026-02-25
A10 Networks, Inc.
REVENUE
$290,557,000
11.03%
INCOME
$42,137,000
-15.96%
EMPLOYEES
494
CUSTOMERS
10
A10 Networks provides secure application and network infrastructure solutions — including application delivery, traffic management, DDoS protection, and WAAP/web and API security — delivered via hardware, virtual, containerized and cloud/SaaS models for enterprises and service providers.
View Company PageFiled: 2026-02-25
Alkermes plc.
REVENUE
$1,475,899,000
-5.25%
INCOME
$241,664,000
-35.06%
EMPLOYEES
2,050
CUSTOMERS
3
Alkermes plc is an Irish‑incorporated global biopharmaceutical company focused on developing, manufacturing, and commercializing proprietary neuroscience medicines and product platforms for CNS disorders including schizophrenia, bipolar I disorder, addiction, narcolepsy and multiple sclerosis.
View Company PageFiled: 2026-02-25
ADMA BIOLOGICS, INC.
REVENUE
$510,173,000
19.63%
INCOME
$146,930,000
-25.67%
EMPLOYEES
647
CUSTOMERS
3
ADMA Biologics, Inc. is a U.S.-based, end-to-end commercial biopharmaceutical company that manufactures, markets, and develops specialty plasma-derived biologics for patients with immune deficiencies and other infectious disease risks.
View Company PageFiled: 2026-02-25
Ares Management Corp
REVENUE
$5,601,482,000
44.19%
INCOME
$527,362,000
13.72%
EMPLOYEES
4,250
CUSTOMERS
2,850
Ares Management Corporation is a global alternative investment manager operating an integrated platform across Credit, Real Assets, Secondaries, and Private Equity with a credit‑oriented, multi‑asset investment approach and $622.5 billion AUM (as of December 31, 2025).
View Company PageFiled: 2026-02-25
AXON ENTERPRISE, INC.
REVENUE
$2,779,536,000
33.47%
INCOME
$124,656,000
-66.94%
EMPLOYEES
N/A
CUSTOMERS
N/A
Axon Enterprise, Inc. is a Scottsdale, Arizona–based technology company (founded 1993) that provides an integrated hardware and cloud-based software platform—SaaS, AI-enabled evidence management, real-time operations, and connected devices (including TASERs, body cameras, and related accessories)—with a mission to protect life and improve public safety.
View Company Page